Analyst picks & changes

Analyst picks & changes

Analyst picks & changes
Company Bank Analyst Coverage Opinion Wk chg 2/9 cls
Achillion (ACHN) JMP Securities Adam Cutler Price target Market outperform -54% $8.87
Cutler lowered his target to $15 from $19 after ACHN and partner Gilead (GILD) discontinued development of GS 9132 (ACH-806), a non-structural protein 4A (NS4A) antagonist, to treat HCV. He expects a backup compound to enter the clinic in 1H08 (see B11).
Affymetrix (AFFX) Piper Jaffray Edward Tenthoff Price target Market perform 9% $27.83
Tenthoff raised his target to $26 from $24 after AFFX reported diluted non-GAAP 4Q06 EPS of $0.15, beating the Street by $0.11. He said the company is doing a good job controlling expenses

Read the full 1178 word article

How to gain access

Continue reading with a
two-week free trial.